Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The SUSTAIN FORTE trial lasted for 40-weeks and enrolled 961 patients with type 2 diabetes with an A1C of 8.0-10.0%
R., & Baxter, L
& Rima Rozen, A
For many patients, 5 mg once weekly provides adequate blood glucose control and represents an effective maintenance dose
That approval does not make tesamorelin a general weight-loss or anti-aging drug for the broader population
This adaptation signals the need for dose progression rather than treatment failure
US$ 25.38
US$ 23.02
US$ 21.87
US$ 28.78
US$ 20.53
US$ 22.42
US$ 28.36
US$ 23.07
US$ 22.28
US$ 27.47
